A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform

Analytical Biochemistry

Volumn 409, Issue 2, 2011, Pages 195-201

  Park, Minyoung ^a   Matsuura, Hisae ^a,b   Lamb, Robert A ^b   Barron, Annelise E ^c   Jardetzky, Theodore S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

5 Helix bundle; Fluorescence polarization; hSRV F protein

Indexed keywords

CONTROLLED DRUG DELIVERY; FLUORESCENCE; PEPTIDES; VIRUSES;

5-HELIX BUNDLE; FLUORESCENCE POLARIZATION; FOOD AND DRUG ADMINISTRATION; FUSION INHIBITORS; RESPIRATORY SYNCYTIAL VIRUS; SCREENING TOOL; THERAPEUTIC INTERVENTION; YOUNG CHILDREN;

POLARIZATION;

PEPTIDE; VIRUS PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; FLUORESCENCE POLARIZATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCREENING TEST;

HUMAN RESPIRATORY SYNCYTIAL VIRUS;

EID: 78650510640     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.10.020     Document Type: Article

References (50)

1. M. Carter, and G.S. Cockerill Inhibitors of respiratory syncytial virus Annu. Rep. Med. Chem. 43 2008 229 245
2. K.L. Powell, and D. Alber Development of antivirals against respiratory syncytial virus Perspect. Med. Virol. 14 2006 279 297
3. P.L. Collins, R.M. Chanock, and B.R. Murphy Respiratory Syncytial Virus 2001 Lippincott Williams and Wilkins Philadelphia
4. S. Leader, and K. Kohlhase Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000 J. Pediatr. 143 2003 S127 S132
5. P.R. Wyde Respiratory syncytial virus (RSV) disease and prospects for its control Antiviral Res. 39 1998 63 79
6. D.K. Shay, R.C. Holman, R.D. Newman, L.L. Liu, J.W. Stout, and L.J. Anderson Bronchiolitis-associated hospitalizations among US children, 1980-1996 JAMA 282 1999 1440 1446
7. P. Stang, N. Brandenburg, and B. Carter The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations Arch. Pediatr. Adolesc. Med. 155 2001 95 96
8. W.P. Glezen, L.H. Taber, A.L. Frank, and J.A. Kasel Risk of primary infection and reinfection with respiratory syncytial virus Am. J. Dis. Child. 140 1986 543 546
9. M. Hashem, and C.B. Hall Respiratory syncytial virus in healthy adults: the cost of a cold J. Clin. Virol. 27 2003 14 21
10. A.R. Falsey, P.A. Hennessey, M.A. Formica, C. Cox, and E.E. Walsh Respiratory syncytial virus infection in elderly and high-risk adults N. Engl. J. Med. 352 2005 1749 1759
11. R.W. Sidwell, and D.L. Barnard Respiratory syncytial virus infections: recent prospects for control Antiviral Res. 71 2006 379 390
12. M.A. Gill, and R.C. Welliver Motavizumab for the prevention of respiratory syncytial virus infection in infants Expert Opin. Biol. Ther. 9 2009 1335 1345
13. X. Zhao, M. Singh, V.N. Malashkevich, and P.S. Kim Structural characterization of the human respiratory syncytial virus fusion protein core Proc. Natl. Acad. Sci. USA 97 2000 14172 14177
14. H.S. Yin, X. Wen, R.G. Paterson, R.A. Lamb, and T.S. Jardetzky Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation Nature 439 2006 38 44
15. H.S. Yin, R.G. Paterson, X. Wen, R.A. Lamb, and T.S. Jardetzky Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein Proc. Natl. Acad. Sci. USA 102 2005 9288 9293
16. K.A. Baker, R.E. Dutch, R.A. Lamb, and T.S. Jardetzky Structural basis for paramyxovirus-mediated membrane fusion Mol. Cell 3 1999 309 319
17. P.M. Colman, and M.C. Lawrence The structural biology of type I viral membrane fusion Nat. Rev. Mol. Cell Biol. 4 2003 309 319
18. S.C. Harrison Viral membrane fusion Nat. Struct. Mol. Biol. 15 2008 690 698
19. S.A. Connolly, G.P. Leser, H.S. Yin, T.S. Jardetzky, and R.A. Lamb Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy Proc. Natl. Acad. Sci. USA 103 2006 17903 17908
20. C.J. Russell, T.S. Jardetzky, and R.A. Lamb Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion EMBO J. 20 2001 4024 4034
21. D.M. Lambert, S. Barney, A.L. Lambert, K. Guthrie, R. Medinas, D.E. Davis, T. Bucy, J. Erickson, G. Merutka, and S.R. Petteway Jr. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion Proc. Natl. Acad. Sci. USA 93 1996 2186 2191
22. D.M. Eckert, and P.S. Kim Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region Proc. Natl. Acad. Sci. USA 98 2001 11187 11192
23. E. Wang, X. Sun, Y. Qian, L. Zhao, P. Tien, and G.F. Gao Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion Biochem. Biophys. Res. Commun. 302 2003 469 475
24. J.L. Douglas, M.L. Panis, E. Ho, K.Y. Lin, S.H. Krawczyk, D.M. Grant, R. Cai, S. Swaminathan, and T. Cihlar Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein J. Virol. 77 2003 5054 5064
25. C. Cianci, D.R. Langley, D.D. Dischino, Y. Sun, K.L. Yu, A. Stanley, J. Roach, Z. Li, R. Dalterio, R. Colonno, N.A. Meanwell, and M. Krystal Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion Proc. Natl. Acad. Sci. USA 101 2004 15046 15051
26. N.E. Shepherd, H.N. Hoang, V.S. Desai, E. Letouze, P.R. Young, and D.P. Fairlie Modular α-helical mimetics with antiviral activity against respiratory syncytial virus J. Am. Chem. Soc. 128 2006 13284 13289
27. D. Rapaport, M. Ovadia, and Y. Shai A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses EMBO J. 14 1995 5524 5531
28. J.K. Young, D. Li, M.C. Abramowitz, and T.G. Morrison Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions J. Virol. 73 1999 5945 5956
29. Y. Shai Functional domains within fusion proteins: prospectives for development of peptide inhibitors of viral cell fusion Biosci. Rep. 20 2000 535 555
30. A.K. Debnath Prospects and strategies for the discovery and development of small-molecule inhibitors of six-helix bundle formation in class 1 viral fusion proteins Curr. Opin. Invest. Drugs 7 2006 118 127
31. L. Ni, L. Zhao, Y. Qian, J. Zhu, Z. Jin, Y.W. Chen, P. Tien, and G.F. Gao Design and characterization of human respiratory syncytial virus entry inhibitors Antiviral Ther. 10 2005 833 840 (Pubitemid 41652977)
32. M.J. Root, M.S. Kay, and P.S. Kim Protein design of an HIV-1 entry inhibitor Science 291 2001 884 888
33. G. Frey, S. Rits-Volloch, X.Q. Zhang, R.T. Schooley, B. Chen, and S.C. Harrison Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion Proc. Natl. Acad. Sci. USA 103 2006 13938 13943
34. H.P. Sorensen, and K.K. Mortensen Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli Microb. Cell Fact. 4 2005 1
35. L. Ni, L. Zhao, G.F. Gao, Y. Qian, and P. Tien The antibodies directed against N-terminal heptad-repeat peptide of hRSV fusion protein and its analog-5-helix inhibit virus infection in vitro Biochem. Biophys. Res. Commun. 331 2005 1358 1364
36. L. Whitmore, and B.A. Wallace Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases Biopolymers 89 2008 392 400
37. A. Lobley, L. Whitmore, and B.A. Wallace DichroWeb: an interactive website for the analysis of protein secondary structure from circular dichroism spectra Bioinformatics 18 2002 211 212
38. J.H. Zhang, T.D. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73
39. A.N. Kirschner, A.S. Lowrey, R. Longnecker, and T.S. Jardetzky Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion J. Virol. 81 2007 9216 9229
40. F. Liu, G. Marquardt, A.N. Kirschner, R. Longnecker, and T.S. Jardetzky Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL using fluorescence polarization and cell-based fusion assays J. Virol. 84 2010 10375 10385
41. J.F. Bonfanti, and D. Roymans Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection Curr. Opin. Drug Discov. Dev. 12 2009 479 487
42. Assay Guidance Manual, Version 5.0, Eli Lilly and NIH Chemical Genomics Center, .
43. S.H. Park, and R.T. Raines Fluorescence polarization assay to quantify protein-protein interactions Methods Mol. Biol. 261 2004 161 166
44. S.M. Knight, N. Umezawa, H.S. Lee, S.H. Gellman, and B.K. Kay A fluorescence polarization assay for the identification of inhibitors of the p53-DM2 protein-protein interaction Anal. Biochem. 300 2002 230 236
45. R. Buchli, R.S. VanGundy, H.D. Hickman-Miller, C.F. Giberson, W. Bardet, and W.H. Hildebrand Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A0201: a new tool for epitope discovery Biochemistry 44 2005 12491 12507
46. J.C. Craig, M.A. Schumacher, S.E. Mansoor, D.L. Farrens, R.G. Brennan, and R.H. Goodman Consensus and variant cAMP-regulated enhancers have distinct CREB-binding properties J. Biol. Chem. 276 2001 11719 11728
47. U. Mathias, and M. Jung Determination of drug-serum protein interactions via fluorescence polarization measurements Anal. Bioanal. Chem. 388 2007 1147 1156
48. Y. Liu, J. Jiang, P.L. Richardson, R.D. Reddy, D.D. Johnson, and W.M. Kati A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A Anal. Biochem. 356 2006 100 107
49. D. Roymans, H.L. De Bondt, E. Arnoult, P. Geluykens, T. Gevers, M. Van Ginderen, N. Verheyen, H. Kim, R. Willebrords, J.F. Bonfanti, W. Bruinzeel, M.D. Cummings, H. van Vlijmen, and K. Andries Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein Proc. Natl. Acad. Sci. USA 107 2010 308 313
50. The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC.